Publication
Abstract
Realization of part of clinical trial called: A 12-Week, Randomized, Double-Blind, Olive Oil-Controlled Phase 3 Study to Assess the Efficacy and Safety of EPANOVA TM in Subjects With Severe Hypertriglyceridemia (EVOLVE II)
Realization of part of clinical trial called: A 12-Week, Randomized, Double-Blind, Olive Oil-Controlled Phase 3 Study to Assess the Efficacy and Safety of EPANOVA TM in Subjects With Severe Hypertriglyceridemia (EVOLVE II)